Professor Julian Peto won a Medal of Honor from the International Agency for Research on Cancer, an agency of the World Health Organization (WHO). The award was based on his research on workplace carcinogens such as asbestos. The researcher's previous work, concerning dose-response models for asbestos cancers such as lung cancer and mesothelioma cancer have been adopted worldwide in asbestos risk assessment.
Mr. Peto was the first to predict the extent to which the mesothelioma epidemic would grow. Mr. Peto has also researched other types of occupational disease. For example, he has researched the workplace risks associated with the manufacture of mustard gas and welding. Outside of the occupational context, Mr. Peto has researched the link between oral contraceptives and breast cancer and childhood leukemia.
Malignant mesothelioma kills thousands of people in the U.S. every year. Common mesothelioma symptoms include coughing of blood, shortness of breath, swelling of the abdomen and fever. Mesothelioma symptoms often appear in the later stages of mesothelioma and thus, treatment options are of limited effectiveness. Some mesothelioma treatment approaches include radiation, gene therapy, immunotherapy and photodynamic therapy.
There are different types of malignant mesothelioma. These include peritoneal mesothelioma and pleural mesothelioma (lung mesothelioma). Peritoneal mesothelioma is a cancer of the lining of the abdominal cavity while pleural mesothelioma is a cancer of the lining of the chest cavity and lungs.
Mesothelioma patients should contact an experienced mesothelioma attorney because they may be entitled to substantial financial compensation from companies that failed to warn of the dangers of asbestos.
No comments:
Post a Comment